Cartesian Therapeutics
RNAC
#8504
Rank
$0.29 B
Marketcap
$9.60
Share price
-3.71%
Change (1 day)
-6.61%
Change (1 year)

Cartesian Therapeutics (RNAC) - Total debt

Total debt on the balance sheet as of March 2026 : $11.85 Million USD

According to Cartesian Therapeutics's latest financial reports the company's total debt is $11.85 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Cartesian Therapeutics - Total debt on balance sheet (from 2015 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$12.67 M-9.35%
2024-12-31$13.98 M27.65%
2023-12-31$10.95 M-71.11%
2022-12-31$37.92 M7.49%
2021-12-31$35.28 M-0.19%
2020-12-31$35.34 M83.37%
2019-12-31$19.27 M-9.86%
2018-12-31$21.38 M1.63%
2017-12-31$21.04 M74.71%
2016-12-31$12.04 M1.59%
2015-12-31$11.85 M60.16%
2014-12-31$7.4 M